Jason C. Sniffen, DO, FACOI, FACP, FIDSA
Infectious Disease Specialist
Dr. Sniffen has practiced infectious diseases in the Orlando area since 2001. He is the immediate past President of Infectious Disease Consultants, MD PA, one of the busiest infectious diseases practices in the United States.
After completing his fellowship training in infectious diseases at the University of South Florida, College of Medicine in Tampa, Florida, Dr. Sniffen relocated to Orlando, but continues to work as a Clinical Assistant Professor in the Department of Infectious Diseases at South Florida College of Medicine. Additionally, Dr. Sniffen teaches medical residents from AdventHealth's many training programs and medical students from Nova Southeastern University on a regular basis.
Dr. Sniffen is Board Certified in Infectious Diseases, Internal Medicine and Hyperbaric Medicine. Dr. Sniffen is the past Chief of Staff and past Chief Medical Adviser at the formerly known Florida Hospital East Orlando location (now AdventHealth East Orlando). He is a former chair of the Pharmacy and Therapeutics Committee for AdventHealth and continues to participate in the ID Expert Section of the Committee as well as the Antibiotic Stewardship Committee.
Dr. Sniffen is a Fellow of the American College of Physicians, American College of Osteopathic internists and has earned the prestigious title of “Fellow of the Infectious Disease Society of America, (FIDSA).” Dr. Sniffen has been repeatedly named to the “Finest Doctors in Orlando” by the Orlando Magazine. At the national level, Dr. Sniffen is past chairman of the American Osteopathic Board of Internal Medicine (AOBIM) and past chairman of the ID Section of the board, a position he held for 11 years and continues to serve as an adviser. On a local and national. level, Dr. Sniffen has dozens of publications to his credit in medical journals, textbooks and on-line.
Dr. Sniffen has received multiple awards of excellence in medicine during his career and was a graduate of the Inaugural Physician Leadership Program at Florida Hospital (now AdventHealth).
Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?
The American journal of gastroenterology
ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida
Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy
CLINICAL INFECTIOUS DISEASES
Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury
OPEN FORUM INFECTIOUS DISEASES
Choosing an appropriate probiotic product for your patient: An evidence-based practical guide
Probiotics and prevention of Clostridium difficile infection
Reducing Collateral Damage Associated With Antibiotic Treatment: Do Less Harm
CLINICAL INFECTIOUS DISEASES
Education & Training
Nova Southeastern University Fort Myers
Rowan Univ. School of Osteopathic Medicine
University Of South Florida
American Osteopathic Board of Internal Medicine